Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks
European CAR-T stocks have jumped following Gilead’s announcement that it will acquire Kite Pharma, Novartis’…
29/08/2017 - 2 minutes
Novartis
Novartis largely dodged deaths from its CAR-T therapy, but FDA still has safety concerns
Editor's Note: Novartis did note a death from cerebral hemorrhage in its hearing with the…
11/07/2017 - 3 minutes
Novartis Scores Major Phase III Win with New Cardiovascular Drug
Novartis just announced that its anti-inflammatory drug, canakinumab, was able to clear a 10,000-plus patient Phase III…
22/06/2017 - 2 minutes
Novartis Tops Ophthalmology Blockbuster Eylea in Phase III Trials
Bayer's and Regeneron's blockbuster Eylea could be facing serious competition, as Novartis boasts with positive…
20/06/2017 - 2 minutes
Novartis Announces New Data for its Psoriasis Blockbuster Cosentyx
Novartis has announced positive post-marketing results for its blockbuster Cosentyx, with which the pharma wants…
15/06/2017 - 1 minute
UK-based VC Launches Massive $300M Fund to Fill Gap for Late-Stage Biotech
The UK-based VC Medicxi has raised a massive $300M (€268M) fund backed by Novartis and…
15/06/2017 - 3 minutes
Novartis Gains Access to Celyad’s allogenic CAR-T cell patents
Belgian Celyad is giving Novartis access to its IP for the production of allogeneic CAR-T…
02/05/2017 - 2 minutes
Novartis Negotiates its Way into the US Migraine Market
Amgen and Novartis have expanded their collaboration for the co-development of their migraine drug, ensuring…
25/04/2017 - 2 minutes
UPDATE: Novartis broadens CAR-T onslaught with FDA endorsement
UPDATE (19/04/2017): CTL019 has been granted Breakthrough Designation by the FDA for relapsed/refractory diffuse large…
19/04/2017 - 3 minutes
Two Big Pharma Players Team up to Take Over the NASH Space
Allergan has entered a clinical collaboration with Novartis to run a Phase IIb study combining…
18/04/2017 - 3 minutes
The Top 12 Biotech Leaders You Should Know in Basel
After exploring Munich and the Golden Triangle, we head to another biotech hotspot full of people…
18/04/2017 - 6 minutes
How is Biotech Transforming Pharma’s R&D Model?
Since the early 2000s, pharma has undergone a major reorganization. What roles do strategic alliances…
06/04/2017 - 4 minutes
